Intragastric Balloons in the Management of Obesity

Publication Date: April 1, 2021
Last Updated: April 8, 2022

Recommendations

1. In individuals with obesity seeking a weight-loss intervention who have failed a trial of conventional weight-loss strategies, AGA suggests the use of IGB therapy with lifestyle modification over lifestyle modification alone. ( Moderate , Conditional (weak) )
612

2. In individuals with obesity undergoing IGB therapy, AGA recommends moderate- to high-intensity concomitant lifestyle modification interventions to maintain and augment weight loss. ( Moderate , Strong )
612

3. In individuals undergoing IGB therapy, AGA recommends prophylaxis with PPIs. ( Moderate , Strong )
612

4. In individuals undergoing IGB therapy, AGA suggests using the intraoperative anesthetic regimens associated with the lowest incidence of nausea along with perioperative antiemetics. AGA suggests a scheduled antiemetic regimen for 2 week after IGB placement. ( Low , Conditional (weak) )
612

5. In individuals undergoing IGB therapy, AGA suggests against perioperative laboratory screening for nutritional deficiencies. ( Low , Conditional (weak) )
612

6. AGA suggests daily supplementation with 1–2 adult dose multivitamins after IGB placement. ( Very Low , Conditional (weak) )
612

7. After IGB removal, AGA suggests subsequent weight-loss or maintenance interventions that include dietary interventions, pharmacotherapy, repeat IGB, or bariatric surgery. The choice of weight-loss or maintenance method after IGB is determined based on patient’s context and comorbidities following a shared decision-making approach. ( Low , Conditional (weak) )
612

Recommendation Grading

Overview

Title

Intragastric Balloons in the Management of Obesity

Authoring Organization

Publication Month/Year

April 1, 2021

Last Updated Month/Year

February 7, 2024

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Inclusion Criteria

Female, Male, Adult

Health Care Settings

Ambulatory, Hospital, Outpatient

Intended Users

Physician, nurse practitioner, nurse, physician assistant

Scope

Management

Diseases/Conditions (MeSH)

D009765 - Obesity

Keywords

obesity, Clinical Practice Guidelines, Intragastric Balloons, Endoscopic bariatric therapies

Supplemental Methodology Resources

Technical Review, Data Supplement